|
1
|
Astarita G and Langridge J: An emerging
role for metabolomics in nutrition science. J Nutrigenet
Nutrigenomics. 6:181–200. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Baraldi E, Carraro S, Giordano G, Reniero
F, Perilongo G and Zacchello F: Metabolomics: Moving towards
personalized medicine. Ital J Pediatr. 35:302009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sun J, Beger DR and Schnackenberg KL:
Metabolomics as a tool for personalizing medicine: 2012 update. Per
Med. 10:149–161. 2013. View
Article : Google Scholar
|
|
4
|
McKillop AM and Flatt PR: Emerging
applications of metabolomic and genomic profiling in diabetic
clinical medicine. Diabetes Care. 34:2624–2630. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tanaka K and Isselbacher KJ: Experimental
beta-hydroxyisovaleric aciduria induced by biotin deficiency.
Lancet. 2:930–931. 1970. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
van der Greef J and Smilde AK: Symbiosis
of chemometrics and metabolomics: past, present, and future.
Chemometrics. 19:376–386. 2005. View
Article : Google Scholar
|
|
7
|
Shaw J: Fathoming Metabolism. The study of
metabolites does an end run around genomics to provide telling
clues to your future health. Harv Mag. 3:27–31. 2011.
|
|
8
|
Horning EC and Horning MG: Metabolic
profiles: gas-phase methods for analysis of metabolites. Clin Chem.
17:802–809. 1971.PubMed/NCBI
|
|
9
|
Pauling L, Robinson AB, Teranishi R and
Cary P: Quantitative analysis of urine vapor and breath by
gas-liquid partition chromatography. Proc Natl Acad Sci USA.
68:2374–2376. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Griffiths WJ and Wang Y: Mass
spectrometry: From proteomics to metabolomics and lipidomics. Chem
Soc Rev. 38:1882–1896. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wishart DS, Tzur D, Knox C, Eisner R, Guo
AC, Young N, Cheng D, Jewell K, Arndt D, Sawhney S, et al: HMDB:
The Human Metabolome Database. Nucleic Acids Res. 35(Database):
D521–D526. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jones PM and Bennett MJ: Urine organic
acid analysis for inherited metabolic disease using gas
chromatography-mass spectrometry. Methods Mol Biol. 603:423–431.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Barshop BA: Metabolomic approaches to
mitochondrial disease: Correlation of urine organic acids.
Mitochondrion. 4:521–527. 2004. View Article : Google Scholar
|
|
14
|
Kumari C, Singh A, Ramji S, Shoemaker JD
and Kapoor S: Urinary Organic Acids Quantitated in a Healthy North
Indian Pediatric Population. Indian J Clin Biochem. 30:221–229.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fiehn O and Spranger J: Use of
metabolomics to discover metabolic patterns associated with human
disease. Pulm Circ. 3:417–423. 2014.
|
|
16
|
Tanaka K, Hine DG, West-Dull A and Lynn
TB: Gas-chromatographic method of analysis for urinary organic
acids. I. Retention indices of 155 metabolically important
compounds. Clin Chem. 26:1839–1846. 1980.PubMed/NCBI
|
|
17
|
Applegarth DA and Ross PM: The
unsuitability of creatinine excretion as a basis for assessing the
excretion of other metabolites by infants and children. Clin Chim
Acta. 64:83–85. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Blau N, Duran M and Gibson KM: Laboratory
Guide to the Methods in Biochemical Genetics. Springer; Berlin
Heidelberg: pp. 7–22. 2008
|
|
19
|
Mitchell P: Possible molecular mechanisms
of the protonmotive function of cytochrome systems. J Theor Biol.
62:327–367. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yousri NA, Mook-Kanamori DO, Selim MM,
Takiddin AH, Al-Homsi H, Al-Mahmoud KA, Karoly ED, Krumsiek J, Do
KT, Neumaier U, et al: A systems view of type 2 diabetes-associated
metabolic perturbations in saliva, blood and urine at different
timescales of glycaemic control. Diabetologia. 58:1855–1867. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Miccheli A, Capuani G, Marini F, Tomassini
A, Praticò G, Ceccarelli S, Gnani D, Baviera G, Alisi A, Putignani
L, et al: Urinary (1)H-NMR-based metabolic profiling of children
with NAFLD undergoing VSL#3 treatment. Int J Obes. 39:1118–1125.
2015. View Article : Google Scholar
|
|
22
|
Legido A, Jethva R and Goldenthal MJ:
Mitochondrial dysfunction in autism. Semin Pediatr Neurol.
20:163–175. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Noto A, Fanos V, Barberini L, Grapov D,
Fattuoni C, Zaffanello M, Casanova A, Fenu G, De Giacomo A, De
Angelis M, et al: The urinary metabolomics profile of an Italian
autistic children population and their unaffected siblings. J
Matern Fetal Neonatal Med. 27(Suppl 2): 46–52. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kałużna-Czaplińska J: Noninvasive urinary
organic acids test to assess biochemical and nutritional
individuality in autistic children. Clin Biochem. 44:686–691. 2011.
View Article : Google Scholar
|
|
25
|
Wu H, Jiang K, Gu G, Wu Y and Yu S: The
relationship of occupational stress and the level of some hormone
metabolites in urine. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za
Zhi. 32:83–86. 2014.In Chinese. PubMed/NCBI
|
|
26
|
Mutsaers HA, Engelke UF, Wilmer MJ,
Wetzels JF, Wevers RA, van den Heuvel LP, Hoenderop JG and
Masereeuw R: Optimized metabolomic approach to identify uremic
solutes in plasma of stage 3–4 chronic kidney disease patients.
PLoS One. 8:e711992013. View Article : Google Scholar
|
|
27
|
Duranton F, Lundin U, Gayrard N, Mischak
H, Aparicio M, Mourad G, Daurès JP, Weinberger KM and Argilés A:
Plasma and urinary amino acid metabolomic profiling in patients
with different levels of kidney function. Clin J Am Soc Nephrol.
9:37–45. 2014. View Article : Google Scholar :
|
|
28
|
Shah VO, Townsend RR, Feldman HI, Pappan
KL, Kensicki E and Vander Jagt DL: Plasma metabolomic profiles in
different stages of CKD. Clin J Am Soc Nephrol. 8:363–370. 2013.
View Article : Google Scholar :
|
|
29
|
Chalmers RA, Valman HB and Liberman MM:
Measurement of 4-hydroxyphenylacetic aciduria as a screening test
for small-bowel disease. Clin Chem. 25:1791–1794. 1979.PubMed/NCBI
|
|
30
|
Li S, Todor A and Luo R: Blood
transcriptomics and metabolomics for personalized medicine. Comput
Struct Biotechnol J. 14:1–7. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nagrath D, Caneba C, Karedath T and
Bellance N: Metabolomics for mitochondrial and cancer studies.
Biochim Biophys Acta. 1807:650–663. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Duez P, Kumps A and Mardens Y: GC-MS
profiling of urinary organic acids evaluated as a quantitative
method. Clin Chem. 42:1609–1615. 1996.PubMed/NCBI
|
|
33
|
Greter J and Jacobson CE: Urinary organic
acids: Isolation and quantification for routine metabolic
screening. Clin Chem. 33:473–480. 1987.PubMed/NCBI
|
|
34
|
Hoffmann G, Aramaki S, Blum-Hoffmann E,
Nyhan WL and Sweetman L: Quantitative analysis for organic acids in
biological samples: Batch isolation followed by gas
chromatographic-mass spectrometric analysis. Clin Chem. 35:587–595.
1989.PubMed/NCBI
|
|
35
|
Bouatra S, Aziat F, Mandal R, Guo AC,
Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P,
et al: The human urine metabolome. PLoS One. 8:e730762013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kiykim E, Zeybek CA, Zubarioglu T,
Cansever S, Yalcinkaya C, Soyucen E and Aydin A: Inherited
metabolic disorders in Turkish patients with autism spectrum
disorders. Autism Res. 9:217–223. 2016. View Article : Google Scholar
|
|
37
|
Boulat O, Gradwohl M, Matos V, Guignard JP
and Bachmann C: Organic acids in the second morning urine in a
healthy Swiss paediatric population. Clin Chem Lab Med.
41:1642–1658. 2003. View Article : Google Scholar
|
